-
1مؤتمر
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
2مؤتمر
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
3مؤتمر
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
4مؤتمر
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
5دورية أكاديمية
المؤلفون: Masashi Ishikawa (738977), Atsuo Takashima (10268537), Yusuke Nagata (7457706), Ryoichi Sawada (10336554), Masahiko Aoki (9520703), Hiroshi Imazeki (11478300), Hidekazu Hirano (11478303), Hirokazu Shoji (6987395), Yoshitaka Honma (547718), Satoru Iwasa (3762730), Natsuko Okita (11478306), Ken Kato (785312), Masayuki Saruta (3543728), Narikazu Boku (10336557)
مصطلحات موضوعية: Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, results also suggested, objective response rate, metastatic colorectal cancer, 18 cases ), tumor growth rate, disease control rate, retrospective study evaluated, indicates tumor shrinkage, 8 cases ), 3 cases ), previously used agents, tumor shrinkage, 30 cases, 12 cases, disease progression,
%22">xlink ">, tumor efficacy, salvage treatment, oxaliplatin based, overall survival, october 2018, occasionally reused, november 2011, median progression -
6دورية أكاديمية
المؤلفون: Masashi Ishikawa (738977), Atsuo Takashima (10268537), Yusuke Nagata (7457706), Ryoichi Sawada (10336554), Masahiko Aoki (9520703), Hiroshi Imazeki (11478300), Hidekazu Hirano (11478303), Hirokazu Shoji (6987395), Yoshitaka Honma (547718), Satoru Iwasa (3762730), Natsuko Okita (11478306), Ken Kato (785312), Masayuki Saruta (3543728), Narikazu Boku (10336557)
مصطلحات موضوعية: Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, results also suggested, objective response rate, metastatic colorectal cancer, 18 cases ), tumor growth rate, disease control rate, retrospective study evaluated, indicates tumor shrinkage, 8 cases ), 3 cases ), previously used agents, tumor shrinkage, 30 cases, 12 cases, disease progression,
%22">xlink ">, tumor efficacy, salvage treatment, oxaliplatin based, overall survival, october 2018, occasionally reused, november 2011, median progression -
7دورية أكاديمية
المؤلفون: Masashi Ishikawa (738977), Atsuo Takashima (10268537), Yusuke Nagata (7457706), Ryoichi Sawada (10336554), Masahiko Aoki (9520703), Hiroshi Imazeki (11478300), Hidekazu Hirano (11478303), Hirokazu Shoji (6987395), Yoshitaka Honma (547718), Satoru Iwasa (3762730), Natsuko Okita (11478306), Ken Kato (785312), Masayuki Saruta (3543728), Narikazu Boku (10336557)
مصطلحات موضوعية: Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, results also suggested, objective response rate, metastatic colorectal cancer, 18 cases ), tumor growth rate, disease control rate, retrospective study evaluated, indicates tumor shrinkage, 8 cases ), 3 cases ), previously used agents, tumor shrinkage, 30 cases, 12 cases, disease progression,
%22">xlink ">, tumor efficacy, salvage treatment, oxaliplatin based, overall survival, october 2018, occasionally reused, november 2011, median progression -
8
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
9
المؤلفون: Natsuki Saigusa (12037538), Hideaki Hirai (2636500), Yuichiro Tada (12037541), Daisuke Kawakita (12037544), Masato Nakaguro (11885864), Kiyoaki Tsukahara (691531), Satoshi Kano (3074064), Hiroyuki Ozawa (5269817), Takahito Kondo (12037547), Kenji Okami (796002), Takafumi Togashi (12037550), Yukiko Sato (424132), Makoto Urano (4319173), Manami Kajiwara (12037553), Tomotaka Shimura (12037556), Chihiro Fushimi (8598222), Akira Shimizu (342338), Isaku Okamoto (12037559), Takuro Okada (12037562), Takayoshi Suzuki (172609), Yorihisa Imanishi (5448881), Yoshihiro Watanabe (2072284), Akihiro Sakai (81092), Koji Ebisumoto (12037565), Yuichiro Sato (306682), Yoshitaka Honma (547718), Keisuke Yamazaki (12037568), Yushi Ueki (12037571), Toyoyuki Hanazawa (5520320), Yuki Saito (230959), Hideaki Takahashi (1269621), Mizuo Ando (4663048), Shinji Kohsaka (849740), Takashi Matsuki (2172334), Toshitaka Nagao (3966755)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, salivary duct carcinoma, EZH2, H3K27me3, androgen receptor, HER2, combined androgen blockade (CAB), prognosis, therapeutic effect
-
10صورة
المؤلفون: Masashi Ishikawa (738977), Atsuo Takashima (10268537), Yusuke Nagata (7457706), Ryoichi Sawada (10336554), Masahiko Aoki (9520703), Hiroshi Imazeki (11478300), Hidekazu Hirano (11478303), Hirokazu Shoji (6987395), Yoshitaka Honma (547718), Satoru Iwasa (3762730), Natsuko Okita (11478306), Ken Kato (785312), Masayuki Saruta (3543728), Narikazu Boku (10336557)
مصطلحات موضوعية: Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Infectious Diseases, results also suggested, objective response rate, metastatic colorectal cancer, 18 cases ), tumor growth rate, disease control rate, retrospective study evaluated, indicates tumor shrinkage, 8 cases ), 3 cases ), previously used agents, tumor shrinkage, 30 cases, 12 cases, disease progression,
%22">xlink ">, tumor efficacy, salvage treatment, oxaliplatin based, overall survival, october 2018, occasionally reused, november 2011, median progression